Alternatives to Catalora

UK biotechnology company developing sustainable natural rubber from engineered dandelions.

Biotechnology startup using genetically engineered insects to convert organic waste into high-value recombinant proteins.

Pioneering sustainable oils and fats through fermentation.

Developing disease-resistant crops using AI-driven platform to resurrect native resistance mechanisms.

Discovering novel agchem solutions targeting protein-protein interactions in pests.

Cultivating wood directly into its final shape, 10,000x faster than forestry.

A biotechnology company focused on genetically engineered salmon for sustainable aquaculture.

Moderna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.

AI-powered discovery and development of sustainable active ingredients for the Ag & Food industries.

Innovating resilient crop seeds using gene-editing technology to combat climate change impacts.

Israeli agritech startup developing novel biological insecticides for crop protection.

AI safety and research company building reliable, interpretable, and steerable AI systems.

Biotechnology company developing and commercializing cell therapies for cancer treatment.

Global biopharmaceutical company pioneering mRNA-based immunotherapies and vaccines for cancer and infectious diseases.

Biotechnology company developing transformative gene-based medicines using CRISPR/Cas9 gene editing technology.

Biotechnology company leveraging ultracompact CRISPR systems for gene editing therapies and diagnostics.

Developing novel therapeutics to restore gut lymphatic function.

Clinical-stage biotechnology company developing autologous neuron replacement medicines for neurodegenerative disorders.

Epicrispr Biotechnologies is a biotechnology company developing novel epigenetic therapies, with a lead program targeting Facioscapulohumeral Muscular Dystrophy (FSHD).

Clinical-stage biotechnology company advancing molecular glue degrader (MGD) medicines.

Spatial multiomics company developing technologies for single-cell gene expression profiling in intact tissues.

Global supplier of life science research tools, including antibodies, reagents, and assays.

Clinical-stage biopharmaceutical company leveraging a proprietary platform to discover and develop novel precision medicines from fungi.

Developing human-derived antibodies for inflammatory diseases and cancer using AI and proprietary platforms.

Biopharmaceutical company developing and commercializing CNS disease treatments.

A vertically-integrated procurement platform for the life sciences industry.

Developing first-and best-in-class antibody-drug conjugates (ADCs) for cancers with high unmet medical need.

A clinical-stage biotechnology company developing inobrodib as a first-in-class, oral p300/CBP inhibitor for the treatment of multiple myeloma.

Enzyme-based technology to break down alcohol in the stomach.

Clinical-stage biopharmaceutical company developing microbiome-derived immunotherapies for cancer and immune diseases.

A leading organization dedicated to curing and treating cystic fibrosis.

A global leader in clinical pharmacology and bioanalytical sciences.

Biopharmaceutical company developing novel small-molecule therapeutics for rare kidney diseases, particularly Autosomal Dominant Polycystic Kidney Disease (ADPKD).

Freenome is a biotechnology company developing a multi-cancer early detection blood test using machine learning and biology.

Personalizing cancer care through a novel, physics-informed approach to predict tumor response to therapy.

BreezeBio is a genetic medicine company developing a pipeline of precision therapeutics.

Developing novel immunotherapies and diagnostics for cancer.

A biotechnology company developing gene therapy treatments for rare, debilitating genetic diseases.

AI-powered precision testing for patient identification in clinics and clinical trials.

A clinical-stage biopharmaceutical company developing novel therapies for neurological disorders.

A clinical-stage biopharmaceutical company developing novel immunotherapies.

A clinical-stage biotechnology company developing in vivo gene editing therapies.

Accelerating patient access to evidence-based innovation in mental health.

A biotechnology company developing genetic therapies for rare disorders.

Developing gene editing therapies to lower cholesterol.

A life sciences company that has developed a high-throughput platform for mapping molecular cell architecture at nanoscale resolution.

A nonprofit research organization leveraging AI and biotechnology to understand and treat complex diseases.

Clinical-stage biopharmaceutical company developing novel treatments for exocrine pancreatic insufficiency.

A venture capital firm that operates multiple accelerators and invests in startups globally.

Developing TCR-mimetic antibody therapies to treat cancer by targeting peptide-loaded major histocompatibility complexes.

AI-driven biotech company engineering novel proteins for therapeutics and sustainability.

AI-powered knowledge discovery for life sciences.

Biotechnology company developing plant-based biomaterials for regenerative medicine and tissue engineering.

The first Integrated Development and Manufacturing Organization (IDMO) for cell therapies.

Biotechnology company advancing novel therapeutics using its proprietary LEADS drug discovery platform.

A biopharmaceutical company focused on the development and commercialization of seralutinib for the treatment of pulmonary arterial hypertension.

Engineering scalable gene therapies for broader patient populations.